Palantir software has reportedly reduced sepsis deaths by over 50% at a Florida hospital, though some market sentiment suggests advancing AI capabilities may eventually provide alternatives to their specific platform. Meanwhile, an AI-based sepsis early warning system commercialized by Bayesian Health has received FDA approval, demonstrating a 20% reduction in mortality rates. These developments highlight increasing competition and clinical success for AI medical tools in the healthcare sector.